Clinical inquiries. For those intolerant to ACE inhibitors and ARBs, what is the best therapy for reducing the risk of diabetic nephropathy?

Santhi Penmetsa, Michael Simmons, Allen Daugird

Journal: The Journal of family practice 2005;54(8):711-3

PMID: 16061061

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Address: Baylor University, Houston, TX, USA.

Link outs

Free resources

Medical:

https://medlineplus.gov/diabetickidneyproblems.htm...

Miscellaneous:

https://assays.cancer.gov/CPTAC-2597

Subscription / membership required

Full Text Sources:

MeSH Terms: Adrenergic beta-Antagonists, Antihypertensive Agents, Atenolol, Calcium Channel Blockers, Diabetic Nephropathies, Diuretics, Humans, Hypertension

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.